China Combination Vaccines Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • A combination vaccine is one that contains two or more living, inactivated organisms or purified antigens that are formulated by producers to prevent multiple diseases.

    This report elaborates on the current development of the Combination Vaccines industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Pfizer Inc

    • Shanghai BravoBio Co, Ltd

    • Bavarian Nordic A/S

    • Takeda Pharmaceutical Company Limited

    • Bharat Biotech International Limited

    • ALK - Abello A/S

    • Sanofi Pasteur SA

    • SK Chemicals Co, Ltd

    • Seqirus

    • GlaxoSmithKline Plc

    • Serum Institute of India Pvt Ltd

    • BiondVax Pharmaceuticals Ltd

    • Altimmune, Inc

    • Hualan Biological Engineering Inc

    • Zydus Cadila

    By Type:

    • Meningococcal Vaccines

    • Pneumococcal Vaccines

    • B Oxysporum

    • Others

    By Application:

    • Child

    • Baby

    • Adult

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Combination Vaccines Market Overview 2018-2029

    • 1.1 China Combination Vaccines Industry Development Overview

    • 1.2 China Combination Vaccines Industry Development History

    • 1.3 China Combination Vaccines Industry Market Size (2018-2029)

    • 1.4 China Combination Vaccines Market Analysis by Type from Production Side

      • 1.4.1 China Combination Vaccines Production Volume, Production Value and Growth Rate of Meningococcal Vaccines (2018-2029)

      • 1.4.2 China Combination Vaccines Production Volume, Production Value and Growth Rate of Pneumococcal Vaccines (2018-2029)

      • 1.4.3 China Combination Vaccines Production Volume, Production Value and Growth Rate of B Oxysporum (2018-2029)

      • 1.4.4 China Combination Vaccines Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • 1.5 China Combination Vaccines Market Analysis by Application from Consumption End

      • 1.5.1 China Combination Vaccines Sales Volume, Sales Value and Growth Rate of Child (2018-2029)

      • 1.5.2 China Combination Vaccines Sales Volume, Sales Value and Growth Rate of Baby (2018-2029)

      • 1.5.3 China Combination Vaccines Sales Volume, Sales Value and Growth Rate of Adult (2018-2029)

    • 1.6 China Combination Vaccines Market Analysis by Region

      • 1.6.1 North China Combination Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Combination Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Combination Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Combination Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Combination Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Combination Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Combination Vaccines Market Size and Growth Rate from 2018-2029

    Chapter 2 China Combination Vaccines Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Combination Vaccines Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Combination Vaccines Market Status and Competition Analysis in 2023

      • 2.2.3 China Combination Vaccines Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Combination Vaccines Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Combination Vaccines Industry Development

    Chapter 3 Combination VaccinesIndustry Chain Analysis

    • 3.1 Combination Vaccines Industry Chain

    • 3.2 Combination Vaccines Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Combination Vaccines Market

    • 3.3 Combination Vaccines Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Combination Vaccines Market

    Chapter 4 China Combination Vaccines Market, by Type

    • 4.1 China Combination Vaccines Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Combination Vaccines Total Production Volume and Growth Rate from Production Side

    • 4.5 China Combination Vaccines Production Volume and Growth Rate, by Type

      • 4.5.1 China Combination Vaccines Production Volume and Growth Rate of Meningococcal Vaccines

      • 4.5.2 China Combination Vaccines Production Volume and Growth Rate of Pneumococcal Vaccines

      • 4.5.3 China Combination Vaccines Production Volume and Growth Rate of B Oxysporum

      • 4.5.4 China Combination Vaccines Production Volume and Growth Rate of Others

    Chapter 5 China Combination Vaccines Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Combination Vaccines Total Market Size and Growth Rate from Consumption End

    • 5.5 China Combination Vaccines Market Size and Growth Rate, by Application

      • 5.5.1 China Combination Vaccines Market Size and Growth Rate of Child

      • 5.5.2 China Combination Vaccines Market Size and Growth Rate of Baby

      • 5.5.3 China Combination Vaccines Market Size and Growth Rate of Adult

    Chapter 6 China Combination Vaccines Market, by Region

    • 6.1 China Combination Vaccines Production Volume and Production Value, by Region

    • 6.2 China Combination Vaccines Sales Volume and Sales Value, by Region

    Chapter 7 North China Combination Vaccines Market Analysis

    • 7.1 North China Combination Vaccines Market, by Type

    • 7.2 North China Combination Vaccines Market, by Application

    Chapter 8 Central China Combination Vaccines Market Analysis

    • 8.1 Central China Combination Vaccines Market, by Type

    • 8.2 Central China Combination Vaccines Market, by Application

    Chapter 9 South China Combination Vaccines Market Analysis

    • 9.1 South China Combination Vaccines Market, by Type

    • 9.2 South China Combination Vaccines Market, by Application

    Chapter 10 East China Combination Vaccines Market Analysis

    • 10.1 East China Combination Vaccines Market, by Type

    • 10.2 East China Combination Vaccines Market, by Application

    Chapter 11 Northeast China Combination Vaccines Market Analysis

    • 11.1 Northeast China Combination Vaccines Market, by Type

    • 11.2 Northeast China Combination Vaccines Market, by Application

    Chapter 12 Southwest China Combination Vaccines Market Analysis

    • 12.1 Southwest China Combination Vaccines Market, by Type

    • 12.2 Southwest China Combination Vaccines Market, by Application

    Chapter 13 Northwest China Combination Vaccines Market Analysis

    • 13.1 Northwest China Combination Vaccines Market, by Type

    • 13.2 Northwest China Combination Vaccines Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Pfizer Inc

        • 14.1.1 Pfizer Inc Company Profile

        • 14.1.2 Pfizer Inc Combination Vaccines Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Shanghai BravoBio Co, Ltd

        • 14.2.1 Shanghai BravoBio Co, Ltd Company Profile

        • 14.2.2 Shanghai BravoBio Co, Ltd Combination Vaccines Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Bavarian Nordic A/S

        • 14.3.1 Bavarian Nordic A/S Company Profile

        • 14.3.2 Bavarian Nordic A/S Combination Vaccines Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Takeda Pharmaceutical Company Limited

        • 14.4.1 Takeda Pharmaceutical Company Limited Company Profile

        • 14.4.2 Takeda Pharmaceutical Company Limited Combination Vaccines Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Bharat Biotech International Limited

        • 14.5.1 Bharat Biotech International Limited Company Profile

        • 14.5.2 Bharat Biotech International Limited Combination Vaccines Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 ALK - Abello A/S

        • 14.6.1 ALK - Abello A/S Company Profile

        • 14.6.2 ALK - Abello A/S Combination Vaccines Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Sanofi Pasteur SA

        • 14.7.1 Sanofi Pasteur SA Company Profile

        • 14.7.2 Sanofi Pasteur SA Combination Vaccines Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 SK Chemicals Co, Ltd

        • 14.8.1 SK Chemicals Co, Ltd Company Profile

        • 14.8.2 SK Chemicals Co, Ltd Combination Vaccines Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Seqirus

        • 14.9.1 Seqirus Company Profile

        • 14.9.2 Seqirus Combination Vaccines Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 GlaxoSmithKline Plc

        • 14.10.1 GlaxoSmithKline Plc Company Profile

        • 14.10.2 GlaxoSmithKline Plc Combination Vaccines Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Serum Institute of India Pvt Ltd

        • 14.11.1 Serum Institute of India Pvt Ltd Company Profile

        • 14.11.2 Serum Institute of India Pvt Ltd Combination Vaccines Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 BiondVax Pharmaceuticals Ltd

        • 14.12.1 BiondVax Pharmaceuticals Ltd Company Profile

        • 14.12.2 BiondVax Pharmaceuticals Ltd Combination Vaccines Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Altimmune, Inc

        • 14.13.1 Altimmune, Inc Company Profile

        • 14.13.2 Altimmune, Inc Combination Vaccines Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Hualan Biological Engineering Inc

        • 14.14.1 Hualan Biological Engineering Inc Company Profile

        • 14.14.2 Hualan Biological Engineering Inc Combination Vaccines Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Zydus Cadila

        • 14.15.1 Zydus Cadila Company Profile

        • 14.15.2 Zydus Cadila Combination Vaccines Market Performance

        • 14.15.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Combination Vaccines Industry Research Conclusions

    • 15.2 Combination Vaccines Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Combination Vaccines Industry Market Size (2018-2029)

    • Figure China Combination Vaccines Production Volume, Production Value and Growth Rate of Meningococcal Vaccines (2018-2029)

    • Figure China Combination Vaccines Production Volume, Production Value and Growth Rate of Pneumococcal Vaccines (2018-2029)

    • Figure China Combination Vaccines Production Volume, Production Value and Growth Rate of B Oxysporum (2018-2029)

    • Figure China Combination Vaccines Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Combination Vaccines Sales Volume, Sales Value and Growth Rate of Child (2018-2029)

    • Figure China Combination Vaccines Sales Volume, Sales Value and Growth Rate of Baby (2018-2029)

    • Figure China Combination Vaccines Sales Volume, Sales Value and Growth Rate of Adult (2018-2029)

    • Figure North China Combination Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Central China Combination Vaccines Market Size and Growth Rate from 2018-2029

    • Figure South China Combination Vaccines Market Size and Growth Rate from 2018-2029

    • Figure East China Combination Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Combination Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Combination Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Combination Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Combination Vaccines Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Combination Vaccines Market Share by Type in 2018

    • Figure China Combination Vaccines Market Share by Type in 2023

    • Figure China Combination Vaccines Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Combination Vaccines Production Volume and Growth Rate of Meningococcal Vaccines (2018-2023)

    • Figure China Combination Vaccines Production Volume and Growth Rate of Pneumococcal Vaccines (2018-2023)

    • Figure China Combination Vaccines Production Volume and Growth Rate of B Oxysporum (2018-2023)

    • Figure China Combination Vaccines Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Combination Vaccines Market Share by Application in 2018

    • Figure China Combination Vaccines Market Share by Application in 2023

    • Figure China Combination Vaccines Total Market Size and Growth Rate from Consumption End

    • Figure China Combination Vaccines Market Size and Growth Rate of Child (2018-2023)

    • Figure China Combination Vaccines Market Size and Growth Rate of Baby (2018-2023)

    • Figure China Combination Vaccines Market Size and Growth Rate of Adult (2018-2023)

    • Table China Combination Vaccines Production Volume by Region (2018-2023)

    • Table China Combination Vaccines Production Volume Share by Region (2018-2023)

    • Figure China Combination Vaccines Production Volume Share by Region (2018-2023)

    • Table China Combination Vaccines Production Value by Region (2018-2023)

    • Table China Combination Vaccines Production Value Share by Region (2018-2023)

    • Figure China Combination Vaccines Production Value Share by Region (2018-2023)

    • Table China Combination Vaccines Sales Volume by Region (2018-2023)

    • Table China Combination Vaccines Sales Volume Share by Region (2018-2023)

    • Figure China Combination Vaccines Sales Volume Share by Region (2018-2023)

    • Table China Combination Vaccines Sales Value by Region (2018-2023)

    • Table China Combination Vaccines Sales Value Share by Region (2018-2023)

    • Figure China Combination Vaccines Sales Value Share by Region (2018-2023)

    • Table North China Combination Vaccines Production Volume by Type (2018-2023)

    • Table North China Combination Vaccines Production Volume Share by Type (2018-2023)

    • Figure North China Combination Vaccines Production Volume Share by Type (2018-2023)

    • Table North China Combination Vaccines Sales Volume by Application (2018-2023)

    • Table North China Combination Vaccines Sales Volume Share by Application (2018-2023)

    • Figure North China Combination Vaccines Sales Volume Share by Application (2018-2023)

    • Table Central China Combination Vaccines Production Volume by Type (2018-2023)

    • Table Central China Combination Vaccines Production Volume Share by Type (2018-2023)

    • Figure Central China Combination Vaccines Production Volume Share by Type (2018-2023)

    • Table Central China Combination Vaccines Sales Volume by Application (2018-2023)

    • Table Central China Combination Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Central China Combination Vaccines Sales Volume Share by Application (2018-2023)

    • Table South China Combination Vaccines Production Volume by Type (2018-2023)

    • Table South China Combination Vaccines Production Volume Share by Type (2018-2023)

    • Figure South China Combination Vaccines Production Volume Share by Type (2018-2023)

    • Table South China Combination Vaccines Sales Volume by Application (2018-2023)

    • Table South China Combination Vaccines Sales Volume Share by Application (2018-2023)

    • Figure South China Combination Vaccines Sales Volume Share by Application (2018-2023)

    • Table East China Combination Vaccines Production Volume by Type (2018-2023)

    • Table East China Combination Vaccines Production Volume Share by Type (2018-2023)

    • Figure East China Combination Vaccines Production Volume Share by Type (2018-2023)

    • Table East China Combination Vaccines Sales Volume by Application (2018-2023)

    • Table East China Combination Vaccines Sales Volume Share by Application (2018-2023)

    • Figure East China Combination Vaccines Sales Volume Share by Application (2018-2023)

    • Table Northeast China Combination Vaccines Production Volume by Type (2018-2023)

    • Table Northeast China Combination Vaccines Production Volume Share by Type (2018-2023)

    • Figure Northeast China Combination Vaccines Production Volume Share by Type (2018-2023)

    • Table Northeast China Combination Vaccines Sales Volume by Application (2018-2023)

    • Table Northeast China Combination Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Combination Vaccines Sales Volume Share by Application (2018-2023)

    • Table Southwest China Combination Vaccines Production Volume by Type (2018-2023)

    • Table Southwest China Combination Vaccines Production Volume Share by Type (2018-2023)

    • Figure Southwest China Combination Vaccines Production Volume Share by Type (2018-2023)

    • Table Southwest China Combination Vaccines Sales Volume by Application (2018-2023)

    • Table Southwest China Combination Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Combination Vaccines Sales Volume Share by Application (2018-2023)

    • Table Northwest China Combination Vaccines Production Volume by Type (2018-2023)

    • Table Northwest China Combination Vaccines Production Volume Share by Type (2018-2023)

    • Figure Northwest China Combination Vaccines Production Volume Share by Type (2018-2023)

    • Table Northwest China Combination Vaccines Sales Volume by Application (2018-2023)

    • Table Northwest China Combination Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Combination Vaccines Sales Volume Share by Application (2018-2023)

    • Table Pfizer Inc Company Profile

    • Table Pfizer Inc Combination Vaccines Revenue, Price and Gross (2018-2023)

    • Table Shanghai BravoBio Co, Ltd Company Profile

    • Table Shanghai BravoBio Co, Ltd Combination Vaccines Revenue, Price and Gross (2018-2023)

    • Table Bavarian Nordic A/S Company Profile

    • Table Bavarian Nordic A/S Combination Vaccines Revenue, Price and Gross (2018-2023)

    • Table Takeda Pharmaceutical Company Limited Company Profile

    • Table Takeda Pharmaceutical Company Limited Combination Vaccines Revenue, Price and Gross (2018-2023)

    • Table Bharat Biotech International Limited Company Profile

    • Table Bharat Biotech International Limited Combination Vaccines Revenue, Price and Gross (2018-2023)

    • Table ALK - Abello A/S Company Profile

    • Table ALK - Abello A/S Combination Vaccines Revenue, Price and Gross (2018-2023)

    • Table Sanofi Pasteur SA Company Profile

    • Table Sanofi Pasteur SA Combination Vaccines Revenue, Price and Gross (2018-2023)

    • Table SK Chemicals Co, Ltd Company Profile

    • Table SK Chemicals Co, Ltd Combination Vaccines Revenue, Price and Gross (2018-2023)

    • Table Seqirus Company Profile

    • Table Seqirus Combination Vaccines Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Plc Company Profile

    • Table GlaxoSmithKline Plc Combination Vaccines Revenue, Price and Gross (2018-2023)

    • Table Serum Institute of India Pvt Ltd Company Profile

    • Table Serum Institute of India Pvt Ltd Combination Vaccines Revenue, Price and Gross (2018-2023)

    • Table BiondVax Pharmaceuticals Ltd Company Profile

    • Table BiondVax Pharmaceuticals Ltd Combination Vaccines Revenue, Price and Gross (2018-2023)

    • Table Altimmune, Inc Company Profile

    • Table Altimmune, Inc Combination Vaccines Revenue, Price and Gross (2018-2023)

    • Table Hualan Biological Engineering Inc Company Profile

    • Table Hualan Biological Engineering Inc Combination Vaccines Revenue, Price and Gross (2018-2023)

    • Table Zydus Cadila Company Profile

    • Table Zydus Cadila Combination Vaccines Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.